CDKN2A and cervical carcinoma: Although Ki-67 biomarkers have been extensively studied in precursor lesions (often together with p16INK4a), relatively fewer and heterogeneous data exist for invasive cervical carcinoma; nevertheless, meta-analyses show that a higher Ki-67/MIB-1 index is associated with worse overall survival in cervical cancer [37].